Tragic Passing of Jockey Michael O'Sullivan Shocks Horse Racing Community

A pioneering pilot study focusing on prostate cancer screening is set to commence next week in Ireland, aiming to prevent thousands of late-stage diagnoses. According to David Galvin, head of the study at the Mater Hospital in Dublin, the initiative combines blood tests, personal risk factors, and MRI scans to enhance screening accuracy for men in their 50s and 60s.
Prostate cancer remains the most frequently diagnosed cancer in men, with 12,000 deaths annually in the UK attributed to late detection, as noted by officials from Prostate Cancer UK. Concerns have arisen that many men receive treatment too late, and the study aims to target screenings, thereby minimizing the risk of unnecessary biopsies.
The PRAISE-U study will randomly invite around 8,000 men in Waterford and Dublin to participate over the next year. It utilizes a multi-stage screening process to ensure that only those requiring further investigation, such as biopsies, undergo invasive procedures. The trial is supported by the European Association of Urology and funded by the EU.